Rat b2M(Beta-2-Microglobulin) ELISA Kit
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC940961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC700961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC700961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC880961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC880961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC050961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC050961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC040961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC040961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC400961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC400961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCB0961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCB0961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCAP0961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCAP0961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCA0961-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), APC conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCR0961-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), RPE conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCP0961-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNUM0961-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), 1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCH0961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNCH0961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNUB0961-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Concentration: 0.2mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNUB0961-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Concentration: 0.2mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC610961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC610961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC550961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC550961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC430961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC430961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC680961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC680961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC470961-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|||
| BNC470961-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF647 conjugate, Concentration: 0.1mg/mL |
|||
B2M Beta-2 Microglobulin Human protein |
|||
| PROTP61769-1 | BosterBio | Regular: 1mg | 380.4 EUR |
|
Description: Human Beta-2 Microglobulin produced in Human urine from patients with tubular proteinuria having a molecular mass of 12KDa and pI of 5.6. |
|||
Rat Beta 2 Microglobulin ELISA Kit |
|||
| IRTB2MKT | Innovative research | each | 780 EUR |
|
Description: Rat Beta 2 Microglobulin ELISA Kit |
|||
Beta 2 Microglobulin (B2M) High Pure (>98%) |
|||
| B2M16-N-1 | Alpha Diagnostics | 1 mg | 489.6 EUR |
Human Beta-2 Microglobulin (B2M) Purified |
|||
| IHUB2M1MG | Innovative research | each | 219 EUR |
|
Description: Human Beta-2 Microglobulin (B2M) Purified |
|||
beta 2 Microglobulin ELISA kit |
|||
| 55R-ORG5BM | Fitzgerald | 96 wells | 411.6 EUR |
|
Description: ELISA kit for the detection of beta 2 Microglobulin in the research laboratory |
|||
Human beta 2-Microglobulin, B2M Protein |
|||
| 20-abx060123 | Abbexa |
|
|
Human beta 2-Microglobulin, B2M Protein |
|||
| abx060235-1mg | Abbexa | 1 mg | 878.4 EUR |
Human beta 2-Microglobulin, B2M Protein |
|||
| abx060262-1mg | Abbexa | 1 mg | 1128 EUR |
Human beta 2-Microglobulin (B2M) Protein |
|||
| abx670062-1mg | Abbexa | 1 mg | 510 EUR |
Human beta 2-Microglobulin (B2M) Protein |
|||
| abx670198-1mg | Abbexa | 1 mg | 560.4 EUR |
Human beta 2-Microglobulin (B2M) Protein |
|||
| abx670241-1mg | Abbexa | 1 mg | 444 EUR |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCA0142-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), APC conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC800142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC800142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC810142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC810142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC940142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC940142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC700142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC700142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC880142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC880142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC430142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC430142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC400142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC400142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC050142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC050142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCAP0142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCAP0142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCB0142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCB0142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCR0142-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), RPE conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNUB0142-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Concentration: 0.2mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNUB0142-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Concentration: 0.2mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCP0142-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNUM0142-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), 1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCH0142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNCH0142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC040142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC040142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC550142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC550142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC610142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC610142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC680142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC680142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC470142-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|||
| BNC470142-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF647 conjugate, Concentration: 0.1mg/mL |
|||
B2M Beta 2 Microglobulin Human Recombinant Protein |
|||
| PROTP61769 | BosterBio | Regular: 50ug | 380.4 EUR |
|
Description: B2 Microglobulin Human Recombinant produced in E.Coli is a non-glycosylated polypeptide chain having a molecular mass of 11.76 kDa.;The B2M is purified by proprietary chromatographic techniques. |
|||
beta-2 Microglobulin ELISA Kit (Rat) (OKIA00134) |
|||
| OKIA00134 | Aviva Systems Biology | 96 Wells | 810 EUR |
|
Description: Description of target: Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. ;Species reactivity: Rat;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.835 ng/ml |
|||
Human beta 2 Microglobulin ELISA kit |
|||
| 55R-2051 | Fitzgerald | 96 tests | 854.4 EUR |
|
Description: ELISA Kit for detection of beta 2 Microglobulin in the research laboratory |
|||
Human Beta 2 Microglobulin ELISA Kit |
|||
| PRB-5038 | Cell Biolabs | 96 assays | 686.4 EUR |
|
Description: Our Human Beta 2 Microglobulin ELISA Kit is a sandwich ELISA for the detection of human beta 2 microglobulin in plasma, serum, lysates, and other biological fluids. Samples or standards are added to an anti-b2M antibody coated plate followed by the addition of an HRP conjugated anti-human b2M antibody. The absorbance is read at 450nm and the level of b2M in samples is determined based on the provided human b2M standard curve. |
|||
Human Beta 2 Microglobulin ELISA Kit |
|||
| IHUB2MKT | Innovative research | each | 787 EUR |
|
Description: Human Beta 2 Microglobulin ELISA Kit |
|||
Beta 2 Microglobulin (B2M) Partially Pure (40-90%) |
|||
| B2M17-N-1 | Alpha Diagnostics | 1 mg | 343.2 EUR |
RealScreen Beta 2 Microglobulin ELISA Kit |
|||
| EL065-096 | GenDepot | 96T | 1161.6 EUR |
Canine Beta-2 microglobulin(B2-MG)ELISA Kit |
|||
| YLA0002CA-48T | Shanghai YL Biotech | 48T | 502.5 EUR |
Canine Beta-2 microglobulin(B2-MG)ELISA Kit |
|||
| YLA0002CA-96T | Shanghai YL Biotech | 96T | 618.75 EUR |
Human Beta-2 Microglobulin (B2M) Purified Lyophilized |
|||
| IHUB2MLY1MG | Innovative research | each | 254 EUR |
|
Description: Human Beta-2 Microglobulin (B2M) Purified Lyophilized |
|||
Polyclonal B2M / Beta 2 Microglobulin Antibody (C-Terminus) |
|||
| APR03270G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human B2M / Beta 2 Microglobulin (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Purified Human beta-2 microglobulin (B2M) protein for ELISA/Standards |
|||
| B2M15-N | Alpha Diagnostics | 50 ug | 343.2 EUR |
Purified Human beta-2 microglobulin (B2M) WB +ve control |
|||
| B2M11-C | Alpha Diagnostics | 100 ul | 343.2 EUR |
Anti-Beta 2 Microglobulin/B2M Antibody |
|||
| A00456-1 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-beta 2 Microglobulin/B2m Antibody |
|||
| A00456-2 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-beta 2 Microglobulin/B2m Antibody |
|||
| A00456-3 | BosterBio | 100ug/vial | 352.8 EUR |
Monoclonal Anti-Human beta-2 microglobulin (B2M) ascites |
|||
| B2M12-M | Alpha Diagnostics | 100 ul | 578.4 EUR |
Beta 2 Microglobulin |
|||
| PR27237 | Neuromics | 50 ug | 381.6 EUR |
beta 2 Microglobulin |
|||
| E8ET1608-45 | EnoGene | 100ul | 275 EUR |
|
Description: Available in various conjugation types. |
|||
Goat Anti-Human beta-2 microglobulin (B2M) IgG, aff pure |
|||
| B2M13-A | Alpha Diagnostics | 100 ug | 578.4 EUR |
Rabbit Anti-Human beta-2 microglobulin (B2M) antiserum # 1 |
|||
| B2M11-S | Alpha Diagnostics | 100 ul | 548.4 EUR |
beta 2-Microglobulin ELISA Kit (Human) (OKIA00054) |
|||
| OKIA00054 | Aviva Systems Biology | 96 Wells | 621.6 EUR |
|
Description: Description of target: Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. Exogenously applied M.tuberculosis EsxA or EsxA-EsxB (or EsxA expressed in host) binds B2M and decreases its export to the cell surface (total protein levels do not change), probably leading to defects in class I antigen presentation.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.822 ng/ml |
|||
Anti-Beta-2 Microglobulin Antibody (B2M/961) |
|||
| A1440-100 | Biovision | each | 574.8 EUR |
Human Beta-2 Microglobulin OneStep ELISA Kit |
|||
| EK7023 | BosterBio | 96wells/kit, with removable strips. | 573.6 EUR |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC941857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC941857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC801857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC801857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC701857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC701857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC881857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC881857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC811857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC811857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC051857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC051857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC041857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC041857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC401857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC401857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCAP1857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCAP1857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCA1857-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), APC conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCP1857-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCR1857-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), RPE conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCH1857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCH1857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCB1857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNCB1857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNUB1857-100 | Biotium | 100uL | 316.8 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Concentration: 0.2mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNUB1857-50 | Biotium | 50uL | 486 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), 1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNUB1857-500 | Biotium | 500uL | 615.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Concentration: 0.2mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC471857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC471857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC611857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC611857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC431857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC431857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC551857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC551857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC681857-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|||
| BNC681857-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/961) Antibody |
|||
| BNUB0961-50 | Biotium | 50uL | 486 EUR |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/961), 1mg/mL |
|||
Human Beta 2 Microglobulin |
|||
| 7-04498 | CHI Scientific | 200µg | Ask for price |
Human Beta 2 Microglobulin |
|||
| 7-04499 | CHI Scientific | 1mg | Ask for price |
Human Beta 2 Microglobulin |
|||
| 7-04500 | CHI Scientific | 10mg | Ask for price |
B2M Human, Beta 2 Microglobulin Human Recombinant Protein, His Tag |
|||
| PROTP61769-2 | BosterBio | Regular: 5ug | 380.4 EUR |
|
Description: B2M Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 120 amino acids (1-119 a.a.) and having a molecular mass of 14 kDa. The B2M is fused to a 21 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. |
|||
Beta-2 Microglobulin Human |
|||
| 22060818-1 | Glycomatrix | 200 µg | 137.27 EUR |
beta 2 Microglobulin protein |
|||
| 30R-3114 | Fitzgerald | 1 mg | 1066.8 EUR |
|
Description: Purified native beta 2 Microglobulin protein |
|||
beta 2 Microglobulin protein |
|||
| 30R-3197 | Fitzgerald | 50 ug | 308.4 EUR |
|
Description: Purified recombinant beta 2 Microglobulin protein |
|||
beta 2 Microglobulin protein |
|||
| 30-1359 | Fitzgerald | 500 ug | 418.8 EUR |
|
Description: Purified recombinant beta 2 Microglobulin protein |
|||
beta 2 Microglobulin Protein |
|||
| abx061021-1mg | Abbexa | 1 mg | 493.2 EUR |
Rat β2 Microglobulin ELISA kit |
|||
| E02M0204-192T | BlueGene | 192 tests | 1524 EUR |
|
Description: A competitive ELISA for quantitative measurement of Rat β2 Microglobulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat β2 Microglobulin ELISA kit |
|||
| E02M0204-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
|
Description: A competitive ELISA for quantitative measurement of Rat β2 Microglobulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat β2 Microglobulin ELISA kit |
|||
| E02M0204-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
|
Description: A competitive ELISA for quantitative measurement of Rat β2 Microglobulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
beta 2 Microglobulin antibody |
|||
| 10-1560 | Fitzgerald | 1 mg | 470.4 EUR |
|
Description: Mouse monoclonal beta 2 Microglobulin antibody |
|||
beta 2 Microglobulin antibody |
|||
| 10-1561 | Fitzgerald | 1 mg | 470.4 EUR |
|
Description: Mouse monoclonal beta 2 Microglobulin antibody |
|||
beta 2 Microglobulin antibody |
|||
| 10-1934 | Fitzgerald | 200 ul | 651.6 EUR |
|
Description: Mouse monoclonal beta 2 Microglobulin antibody |
|||
beta 2 Microglobulin antibody |
|||
| 20R-MR013 | Fitzgerald | 100 µg | 796.8 EUR |
|
Description: Rabbit polyclonal beta 2 Microglobulin antibody |
|||
beta 2 Microglobulin antibody |
|||
| 20C-CR2010SP | Fitzgerald | 1 ml | 439.2 EUR |
|
Description: Sheep polyclonal beta 2 Microglobin antibody |
|||
beta 2 Microglobulin antibody |
|||
| 20-MS30 | Fitzgerald | 1 ml | 457.2 EUR |
|
Description: Sheep polyclonal beta 2 Microglobulin antibody |
|||
Beta 2 Microglobulin Antibody |
|||
| abx024163-10mg | Abbexa | 10 mg | 910.8 EUR |
beta 2 Microglobulin antibody |
|||
| 70R-5904 | Fitzgerald | 50 ug | 560.4 EUR |
|
Description: Rabbit polyclonal beta 2 Microglobulin antibody raised against the N terminal of B2M |
|||
Beta 2 Microglobulin antibody |
|||
| 70R-7564 | Fitzgerald | 1 mg | 386.4 EUR |
|
Description: Affinity purified Goat polyclonal Beta 2 Microglobulin antibody |
|||
beta 2 Microglobulin Antibody |
|||
| 35366-100ul | SAB | 100ul | 468 EUR |
beta 2 Microglobulin Antibody |
|||
| 48829-100ul | SAB | 100ul | 399.6 EUR |
beta 2 Microglobulin Antibody |
|||
| 48829-50ul | SAB | 50ul | 286.8 EUR |
Mouse Beta-2 microglobulin ELISA Kit, 96 tests, Quantitative |
|||
| 9245 | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/1118 (Concentrate) |
|||
| RA0424-C.5 | ScyTek Laboratories | 0.5 ml | 360 EUR |
Beta-2 Microglobulin Antibody |
|||
| 48016-100ul | SAB | 100ul | 399.6 EUR |
Beta-2 Microglobulin Antibody |
|||
| 48016-50ul | SAB | 50ul | 286.8 EUR |
Beta-2 Microglobulin Antibody |
|||
| V3538-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3538-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3538IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3538SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3539-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3539-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3539IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3539SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V3704-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V3704-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V3704IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V3704SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V7123-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V7123-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V7123IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V7123SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
|||
Beta-2 Microglobulin Antibody |
|||
| V2800-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
|||
Beta-2 Microglobulin Antibody |
|||
| V2800-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
|||
Beta-2 Microglobulin Antibody |
|||
| V2800IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
|||
Beta-2 Microglobulin Antibody |
|||
| V2800SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
|||
Beta-2 Microglobulin Antibody |
|||
| V2801-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2801-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2801IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2801SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2802-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha- heavy chain that contains three subdomains (alpha-1, alpha-2, alpha-3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha-3 subdomain of the alpha- heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha-1 and alpha-2 domains of the alpha- heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2802-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha- heavy chain that contains three subdomains (alpha-1, alpha-2, alpha-3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha-3 subdomain of the alpha- heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha-1 and alpha-2 domains of the alpha- heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2802SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha- heavy chain that contains three subdomains (alpha-1, alpha-2, alpha-3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha-3 subdomain of the alpha- heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha-1 and alpha-2 domains of the alpha- heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2803-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: The antibody recognizes the hidden determinant of beta-2 microglobulin (i.e. binding to its determinant is available only when the chain is separated from the HLA heavy chain). Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta-2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
|||
Beta-2 Microglobulin Antibody |
|||
| V2803-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: The antibody recognizes the hidden determinant of beta-2 microglobulin (i.e. binding to its determinant is available only when the chain is separated from the HLA heavy chain). Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta-2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
|||
Beta-2 Microglobulin Antibody |
|||
| V2803SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: The antibody recognizes the hidden determinant of beta-2 microglobulin (i.e. binding to its determinant is available only when the chain is separated from the HLA heavy chain). Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta-2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
|||
Beta-2 Microglobulin Antibody |
|||
| V2804-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2804-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Beta-2 Microglobulin Antibody |
|||
| V2804IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
|||
Rat b2M(Beta-2-Microglobulin) ELISA Kit